The importance of the MELK/FOXM1 complex even gets bolder when EZH2, as an emerging therapeutic molecule in brain tumors [45], was confirmed to be a target of this complex in GBM spheres [46]. This evidence concerns the gene FOXM1 and glioblastoma.